Tag:
cancer drugs
Latest Headlines
Latest Headlines
ASCO data to shine new light on Pfizer, Roche, J&J drugs
Cancer drug aficionados, rejoice. A slew of new studies goes public later today, as drugmakers gear up for next month's American Society of Clinical Oncology meeting.
Top 10 Best-selling Cancer Drugs in 2011
Oncology drugs are hot. Scratch beneath the surface of most major drugmakers, and you'll find a host of them in various stages of development.
Patients put a high value on cancer meds--and on hope
One recent study found that patients valued treatments for advanced cancer at 24 times their actual cost, on average.
More phony Avastin pops up in U.S.
This time, the counterfeit version of Roche's cancer drug came from a different distribution network, and it was packaged differently.
Can pricey cancer drugs outlast austerity?
Soaring price tags are running up against cost-cutting pressures from governments, private payers and patients.
Bayer eyes 16% pharma growth on new meds
Bayer CEO Marijn Dekkers is touting Xarelto 's multibillion-dollar prospects again. This time, though, it's just one of four prospective blockbusters drawing Dekkers' praise.
Indian government forces Bayer to accept generic Nexavar competition
India has invoked its compulsory licensing rules for the first time, allowing the domestic drugmaker Natco Pharma to make and sell a version of Bayer's cancer drug Nexavar--despite the fact that...
New Zytiga use could double sales potential
Analysts are rejigging their sales estimates for Johnson & Johnson's prostate cancer pill Zytiga , on the promise that it could target a much larger set of patients.
FDA calls on contractors, India to counter Ben Venue drug shortages
A non-FDA approved drug from India and U.S. contract manufacturers will address cancer drug shortages resulting from production and quality problems at Ben Venue Laboratories ' now notorious Ohio...
APP, Hospira resolve shortage of cytarabine
One of the many cancer drug shortages--of cytarabine, a treatment for acute myeloid leukemia--has been resolved. Drugmakers APP Pharmaceuticals ( $APPX ) and Hospira ( $HSP ) report "good supply" and
